文献速递胰腺与胆道疾病消化内镜

评估闪烁警示灯减少ERCP术中透视时间与辐射暴露短期效果的单中心前瞻性随机预试验

A pilot single-center prospective randomized trial to assess the short-term effect of a flashing warning light on reducing fluoroscopy time and radiation exposure during ERCP.
PubMed 文献 · Gastrointest Endosc · 2018-03-17

本研究为单中心前瞻性随机预试验,纳入200例治疗性ERCP,按1:1随机分为警示灯组与对照组,警示灯在踩下透视脚踏时亮起。警示灯组中位透视时间和剂量面积乘积均低于对照组,多变量分析显示使用警示灯使透视时间减少15.4%。作者认为闪烁警示灯是减少ERCP术中透视时间和辐射暴露的可行方式。

要点

  • 警示灯组中位透视时间142.5秒 vs 对照组175.0秒(P = .045)。
  • 警示灯组中位剂量面积乘积856.8 μGy∙m2 vs 对照组1054.4 μGy∙m2(P = .043)。
  • 多变量分析显示使用警示灯使透视时间减少15.4%(-27.0秒;P = .042)。

核心结论

  • 作者认为使用闪烁警示灯是减少ERCP术中透视时间和辐射暴露的可行方式。

研究设计与样本

  • 单中心前瞻性随机预试验,纳入200例治疗性ERCP,连续入组并按1:1比例随机分为警示灯组和对照组。
  • 警示灯置于内镜监视器上方,警示灯组在踩下透视脚踏时灯亮,对照组灯不亮,记录透视及操作相关数据。

主要发现

  • 警示灯组中位透视时间142.5秒 vs 对照组175.0秒(P = .045)。
  • 警示灯组中位剂量面积乘积856.8 μGy∙m2 vs 对照组1054.4 μGy∙m2(P = .043)。
  • 多变量分析显示使用警示灯使透视时间减少15.4%(-27.0秒;P = .042)。
  • 因透视时间减少带来的剂量面积乘积降低为15.2%(160.3 μGy∙m2)。
  • 每例患者有效剂量减少0.42 mSv,相当于21张胸部X线片。

临床怎么用

  • 作者认为使用闪烁警示灯是减少ERCP术中透视时间和辐射暴露的可行方式。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: ERCP has the risk of exposure to ionizing radiation. Performers may unconsciously increase fluoroscopy time (FT) because of a lack of radiation protection awareness. This study investigates whether a flashing warning light adopted as a behavioral intervention for performers reduces FT and radiation exposure during ERCP. METHODS: We conducted a prospective randomized trial of 200 therapeutic ERCPs. A flashing warning light was placed on top of the endoscopy monitor. Cases were consecutively enrolled and randomly assigned to 2 groups in a 1:1 ratio. In the warning light group, the light was on when the fluoroscopy foot pedal was depressed; in the control group, the light was off. Fluoroscopy and procedure-related data were recorded. RESULTS: The median FT and dose-area product (DAP) for the warning light group versus the control group were 142.5 seconds versus 175.0 seconds (P = .045) and 856.8 μGy∙m2 versus 1054.4 μGy∙m2 (P = .043). In a multivariable analysis, the use of the warning light was found to reduce FT by 15.4% (-27.0 seconds; P = .042). DAP reduction because of the decreased FT was 15.2% (160.3 μGy∙m2). The reduction in patient effective dose per case was .42 mSv, equivalent to 21 chest radiographs. No adverse events or interference with the procedures because of the warning light were noted. CONCLUSIONS: The use of a flashing warning light is a feasible way to reduce FT and radiation exposure during ERCP. (Clinical trial registration number: ChiCTR-IPR-14005349.).

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Zeng HZ, Liu Q, Chen HL, et al. A pilot single-center prospective randomized trial to assess the short-term effect of a flashing warning light on reducing fluoroscopy time and radiation exposure during ERCP. Gastrointest Endosc. 2018. PMID: 29559225. doi:10.1016/j.gie.2018.03.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。